Have a personal or library account? Click to login
Spontaneous regression of severe aortic stenosis after massive embolization in a patient with antiphospholipid syndrome Cover

Spontaneous regression of severe aortic stenosis after massive embolization in a patient with antiphospholipid syndrome

Seminars in Cardiovascular Medicine
Volume 25 (2019): Issue 1 (January 2019)
By: Ali Youssef,  Mustafa Alrefae and  Sayed Abouelsoud  
Open Access
|Apr 2019

References

  1. [1] Khamashta MA, Amigo MC. Antiphospholipid syndorme: overview of pathogenesis, diagnosis, and management. In: Hochberg MC, Silman AJ, Smolen JS, Weinblatt ME,Weisman MH, editors. Rheumatology, 6. Vol. 2. Philadelphia: Elsevier; 2015. p. 1144–52.
    Search in Google ScholarBack to article
  2. [2] Ruiz-Irastorza G, CrowtherM, BranchW, Khamashta MA. Antiphospholipid syndrome. Lancet 2010;376:1498–509.10.1016/S0140-6736(10)60709-X
    Search in Google ScholarBack to article
  3. [3] Perez-Villa F, Font J, Azqueta M, Espinosa G, Pare C, Cervera R, et al. Severe valvular regurgitation and antiphospholipid antibodies in systemic lupus erythematosus: a prospective, long-term, follow up study. Arthritis Rheum 2005;53:460–7.10.1002/art.21162
    Search in Google ScholarBack to article
  4. [4] Gabrielli F, Alcini E, di Prima MA, Mazzacurati G, Masala C. Cardiac valve involvement in systemic lupus erythematosus and primary antiphospholipid syndrome: lack of correlation with antiphospholipid antibodies. Int J Cardiol 1995;51:117–26.10.1016/0167-5273(95)02357-3
    Search in Google ScholarBack to article
  5. [5] Borowski A, Ghodsizad A, Cohnen M, Gams E. Recurrent embolism in the course of marantic endocarditis. Ann Thorac Surg 2005;79:2145–7.10.1016/j.athoracsur.2003.12.024
    Search in Google ScholarBack to article
  6. [6] Eiken PW, Edwards WD, Tazelaar HD, McBane RD, Zehr KJ. Surgical pathology of nonbacterial thrombotic endocarditis in 30 patients, 1985–2000. Mayo Clin Proc 2001;76:1204–12.10.4065/76.12.1204
    Search in Google ScholarBack to article
  7. [7] Moyssakis I, Tzioufas A, Triposkiadis F, Strateges N, Kyriakidis M. Severe aortic stenosis and mitral regurgitation in a woman with systemic lupus erythematosus. Clin Cardiol 2002;4:194–6.10.1002/clc.4960250412
    Search in Google ScholarBack to article
  8. [8] Muscal E, Brey RL. Neurologic manifestations of the antiphospholipid syndrome: integrating molecular and clinical lessons. Curr Rheumatol Rep 2008;10:67–73.10.1007/s11926-008-0012-y
    Search in Google ScholarBack to article
  9. [9] Denas G, Jose SP, Bracco A, Zoppellaro G, Pengo V. Antiphospholipid syndrome and the heart: a case series and literature review. Autoimmun Rev 2015;14:214–22.10.1016/j.autrev.2014.11.003
    Search in Google ScholarBack to article
  10. [10] Jouhikainen T, Pohjola-Sintonen S, Stephansson E. Lupus anticoagulant and cardiac manifestations in systemic lupus erythematosus. Lupus 1994;3:167–72.10.1177/096120339400300307
    Search in Google ScholarBack to article
  11. [11] Leung WH, Wong KL, Lau CP, Wong CK, Liu HW. Association between antiphospholipid antibodies and cardiac abnormalities in patients with systemic lupus erythematosus. Am J Med 1990;89:411–9.10.1016/0002-9343(90)90368-N
    Search in Google ScholarBack to article
  12. [12] Espínola-Zavaleta N, Vargas-Barrón J, Colmenares-Galvis T, Cruz-Cruz F, Romero-Cárdenas A, Keirns C, et al. Echocardiographic evaluation of patients with primary antiphospholipid syndrome. Am Heart J 1999;137:973–8.10.1016/S0002-8703(99)70424-2
    Search in Google ScholarBack to article
  13. [13] Hojnik M, George J, Ziporen L, Shoenfeld Y. Heart valve involvement (Libman–Sacks endocarditis) in the antiphospholipid syndrome. Circulation 1996;93:1579–87.10.1161/01.CIR.93.8.1579
    Search in Google ScholarBack to article
  14. [14] Morelli S, Bernardo ML, Viganego F, Sgreccia A, De Marzio P, Conti F, et al. Left-sided heart valve abnormalities and risk of ischemic cerebrovascular accidents in patients with systemic lupus erythematosus. Lupus 2003;12:805–12.10.1191/0961203303lu468oa
    Search in Google ScholarBack to article
  15. [15] Roldan CA, Shively BK, Crawford MH. An echocardiographic study of valvular heart disease associated with systemic lupus erythematosus. N Engl J Med 1996;335:1424–30.10.1056/NEJM199611073351903
    Search in Google ScholarBack to article
  16. [16] Turiel M, Sarzi-Puttini P, Peretti R, Bonizzato S, Muzzupappa S, Atzeni F, et al. Five-year follow-up by transesophageal echocardiographic studies in primary antiphospholipid syndrome. Am J Cardiol 2005;96:574–9.10.1016/j.amjcard.2005.04.022
    Search in Google ScholarBack to article
  17. [17] Dentali F, Manfredi E, Crowther M, Ageno W. Longduration therapy with low molecular weight heparin in patients with antiphospholipid antibody syndrome resistant to warfarin therapy. J Thromb Haemost 2005;3:2121–3.10.1111/j.1538-7836.2005.01516.x
    Search in Google ScholarBack to article
  18. [18] Sciascia S, Khamashta MA, D’Cruz DP. Targeted therapy in antiphospholipid syndrome. Curr Opin Rheumatol 2014;26:269–75.10.1097/BOR.0000000000000051
    Search in Google ScholarBack to article
  19. [19] Bakshi J, Stevens R. Rituximab therapy for recurrent thromboembolic disease in antiphospholipid syndrome. Lupus 2013;22:865–7.10.1177/0961203313491023
    Search in Google ScholarBack to article
  20. [20] Dufrost V, Risse J, Zuily S, Wahl D. Direct Oral Anticoagulants Use in Antiphospholipid Syndrome: Are These Drugs an Effective and Safe Alternative to Warfarin? A Systematic Review of the Literature. Curr Rheumatol Rep 2016;18:74.10.1007/s11926-016-0623-7
    Search in Google ScholarBack to article
  21. [21] Cohen H, Hunt BJ, Efthymiou M, Arachchillage DJ, Mackie IJ, Clawson S, et al. Rivaroxaban versus warfarin to treat patients with thrombotic antiphospholipid syndrome, with or without systemic lupus erythematosus (RAPS): a randomized, controlled, open-label, phase 2/3, non-inferiority trial. Lancet Haematol 2016;3:426–36.10.1016/S2352-3026(16)30079-5
    Search in Google ScholarBack to article
  22. [22] Nesher G, Ilany J, Rosenmann D, Abraham AS. Valvular dysfunction in antiphospholipid syndrome: prevalence, clinical features, and treatment. Semin Arthritis Rheum 1997;27:27–35.10.1016/S0049-0172(97)80034-0
    Search in Google ScholarBack to article
  23. [23] Erdozain JG, Ruiz-Irastorza G, Segura MI, Amigo MC, Espinosa G, Pomar JL, et al. Cardiac Valve Replacement in Patients with Antiphospholipid Syndrome. Arthritis Care Res (Hoboken) 2012;64:1256–60.10.1002/acr.2167022422594
    Search in Google ScholarBack to article
  24. [24] Gorki H, Malinovski V, Stanbridge RD. The antiphospholipid syndrome and heart valve surgery. Eur J Cardiothorac Surg 2008;33:168–81.10.1016/j.ejcts.2007.11.00418082413
    Search in Google ScholarBack to article
DOI: https://doi.org/10.2478/semcard-2019-0002 | Journal eISSN: 1822-7767
Journal RSS Feed
Language: English
Page range: 4 - 8
Submitted on: Nov 23, 2018
|
Accepted on: Feb 18, 2019
|
Published on: Apr 1, 2019
Published by: Sciendo
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
antiphospholipid syndrome,
aortic stenosis,
embolization
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Internal medicine, other,
Cardiology

© 2019 Ali Youssef, Mustafa Alrefae, Sayed Abouelsoud, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous articleVolume 25 (2019): Issue 1 (January 2019)Next article